BE897470A - Procede de production de glycoproteines antitumorales - Google Patents

Procede de production de glycoproteines antitumorales Download PDF

Info

Publication number
BE897470A
BE897470A BE0/211308A BE211308A BE897470A BE 897470 A BE897470 A BE 897470A BE 0/211308 A BE0/211308 A BE 0/211308A BE 211308 A BE211308 A BE 211308A BE 897470 A BE897470 A BE 897470A
Authority
BE
Belgium
Prior art keywords
sep
glycoprotein
surfactant
molecular weight
group formed
Prior art date
Application number
BE0/211308A
Other languages
English (en)
French (fr)
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of BE897470A publication Critical patent/BE897470A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BE0/211308A 1982-08-04 1983-08-04 Procede de production de glycoproteines antitumorales BE897470A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57135852A JPS5925332A (ja) 1982-08-04 1982-08-04 抗腫瘍性糖蛋白質の製法

Publications (1)

Publication Number Publication Date
BE897470A true BE897470A (fr) 1984-02-06

Family

ID=15161271

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/211308A BE897470A (fr) 1982-08-04 1983-08-04 Procede de production de glycoproteines antitumorales

Country Status (21)

Country Link
JP (1) JPS5925332A (da)
KR (1) KR840006127A (da)
AU (1) AU1759283A (da)
BE (1) BE897470A (da)
BR (1) BR8304143A (da)
DD (1) DD213440A5 (da)
DE (1) DE3328239A1 (da)
DK (1) DK356483A (da)
FI (1) FI832776A (da)
FR (1) FR2531435A1 (da)
GB (1) GB2125048A (da)
GR (1) GR78638B (da)
IT (1) IT8348806A0 (da)
LU (1) LU84946A1 (da)
NL (1) NL8302765A (da)
NO (1) NO832811L (da)
PL (1) PL243306A1 (da)
PT (1) PT77154B (da)
SE (1) SE8304276L (da)
YU (1) YU161983A (da)
ZA (1) ZA835680B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2161813B (en) * 1984-07-20 1988-07-13 Michiko Koga Anti-tumor agent
JP3439490B2 (ja) * 1992-09-28 2003-08-25 株式会社林原生物化学研究所 蛋白質とその蛋白質をコードするｄｎａ並びにその蛋白質の製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073293B1 (da) * 1969-12-31 1973-01-12 Pasteur Institut
WO1980002375A1 (en) * 1977-09-23 1980-11-13 Hem Res Inc High purity animal interferons

Also Published As

Publication number Publication date
GR78638B (da) 1984-09-27
YU161983A (en) 1986-02-28
DE3328239A1 (de) 1984-02-16
AU1759283A (en) 1984-02-09
BR8304143A (pt) 1984-03-13
FR2531435A1 (fr) 1984-02-10
PT77154B (en) 1986-01-28
IT8348806A0 (it) 1983-08-03
FI832776A0 (fi) 1983-08-02
KR840006127A (ko) 1984-11-22
PT77154A (en) 1983-09-01
DK356483A (da) 1984-02-05
FI832776A (fi) 1984-02-05
SE8304276D0 (sv) 1983-08-04
PL243306A1 (en) 1984-08-27
ZA835680B (en) 1984-08-29
JPS5925332A (ja) 1984-02-09
GB8320547D0 (en) 1983-09-01
LU84946A1 (fr) 1983-12-28
NO832811L (no) 1984-02-06
DD213440A5 (de) 1984-09-12
NL8302765A (nl) 1984-03-01
SE8304276L (sv) 1984-02-05
DK356483D0 (da) 1983-08-04
GB2125048A (en) 1984-02-29

Similar Documents

Publication Publication Date Title
EP0912197B1 (de) Hämoglobin-hydroxyethylstärke-konjugate als sauerstoff-transport-mittel
AU590872B2 (en) Neovascularization inhibitors and methods for their production and use
FI68519C (fi) Foerfarande foer framstaellning av interferon
DE69730352T2 (de) Verfahren zur herstellung eines arzneimittelkomplexes
FI72124B (fi) Foerfarande foer tillvaratagande av interferon
LU84662A1 (fr) Nouvelles glycoproteines,procedes pour leur preparation et agents therapeutiques contenant ces glycoproteines en vue de combattre les tumeurs
JPS61215329A (ja) 血液代用物および血漿増量剤として使用する製剤並びにその製造方法
EP0325270A2 (en) Anticancer conjugates
FI72143C (fi) Foerfarande foer framstaellning av maenniskointerferon.
DE69220375T2 (de) Makrophagen aktivierender faktor aus tierischem vitamin-d bindendem protein
FR2556220A1 (fr) Nouveau lymphokine et anticorps monoclonal specifique de ce lymphokine, leur production et leurs utilisations
BE897470A (fr) Procede de production de glycoproteines antitumorales
EP0242302B1 (fr) Nouveau matériau pour chromatographie d'affinité et son application à la séparation et à la purification des antigènes protéiques des bactéries du genre Bordetella
JPS58192896A (ja) インタ−フエロン
JPS62500518A (ja) 免疫毒素及びその製造方法
FR2601678A1 (fr) Peptides comprenant la sequence seryl-aspartyl-lysyl-prolyle, procede pour l'extraction du tetrapeptide correspondant, et applications, notamment a la protection de la moelle osseuse au cours de traitements anticancereux par la chimiotherapie
EP0136093A2 (en) Anti-cancer factors
CZ289560B6 (cs) Způsob výroby přípravku obsahujícího hyaluronidázu
US6015878A (en) Antitumor agents isolated from intestinal mucosa, a method for their isolation and their application
BE873594A (fr) Interferon et preparation le contenant
FI77157C (fi) Foerfarande foer framstaellning av glykobunden antigen och foerfarande foer framstaellning av foer kancerceller toxiska lymfocyter, som aer specifika mot denna antigen.
US20070219126A1 (en) Class of bioactive glycoprotein
BE1006134A6 (fr) Procede de preparation de derives 2-desoxy-2-amino hexuronyles d'heparine, derives tels qu'ainsi obtenus et leur utilisation.
Laerum et al. Biological and chemical properties of the hemoregulatory peptide and possibilities for clinical applications
FR2536281A1 (fr) Compositions pharmaceutiques permettant de reguler les fonctions phagocytaires

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: MOCHIDA PHARMACEUTICAL CO. LTD

Effective date: 19850831